Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1764-1768

  Knowles, Helen J ^a   Raval, Raju R ^a,b   Harris, Adrian L ^a   Ratcliffe, Peter J ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRON;

ALPHA CHAIN; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON THERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE CULTURE;

ADENOCARCINOMA; ASCORBIC ACID; BREAST NEOPLASMS; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; FEMALE; FERROUS COMPOUNDS; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; NEOPLASMS; OVARIAN NEOPLASMS; PROCOLLAGEN-PROLINE DIOXYGENASE; PROSTATIC NEOPLASMS; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFERRIN; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037446983     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Semenza, G. L. HIF-1 and human disease: one highly involved factor. Genes Dev., 14: 1983-1991, 2000.
2. Epstein, A. C. R., Gleadle, G. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole. D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian, Y-M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P. H., Pugh, C. W., Schofield, C. J., and Ratcliffe, P. J. C. elegans EGL-9 and mammalian homologues define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 107: 43-54, 2001.
3. Bruick, K. B., and McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science (Wash. DC), 294: 1337-1340, 2001.
4. Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y-M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M., Ratcliffe, P. J., Pugh, C. W., and Schofield, C. J. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem., 277: 26351-26355, 2002.
5. Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., and Bruick, R. K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev., 16: 1466-1471, 2002.
6. Kivirikko, K. I., and Myllyharju, J. Prolyl 4-hydroxylases and their protein disulphide isomerase subunit. Matrix Biol., 16: 357-368, 1997.
7. Cockmann, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., and Maxwell, P. H. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem., 275: 25733-25741, 2000.
8. Vlietstra, R. J., van Alewijk, D. C., Hermans, K. G., van Steenbrugge, G. J., and Trapman, J. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res., 58: 2720-2723, 1998.
9. Isaacs, W. B., Carter, B. S., and Ewing, C. M. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res., 51: 4716-4720, 1991.
10. Zhong, H., Agani, F., Baccala, A. A., Laughner, E., Rioseco-Camacho, N., Isaacs, W. B., Simons, J. W., and Semenza, G. L. Increased expression of hypoxia-inducible factor-1 α in rat and human prostate cancer. Cancer Res., 58: 5280-5284, 1998.
11. Rietjens, I. M. C. M., Boersma, M. G., de Haan, L., Spenkelink, B., Awad, H. M., Cnubben, N. H. P., van Zanden, J. J., van Der Woude, H., Alink, G. M., and Koeman, J. H. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Env. Toxicol. Pharmacol., 11: 321-333, 2002.
12. Ho, V. T., and Bunn, H. F. Effects of transition metals on the expression of the erythropoietin gene: further evidence that the oxygen sensor is a heme protein. Biochem. Biophys. Res. Commun., 223: 175-180, 1996.
13. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., Stokoe, D., and Giaccia, A. J. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev., 14: 391-396, 2000.
14. c-src leads to elevated hypoxia-inducible factor (HIF)-1α expression under normoxia. J. Biol. Chem., 277: 42919-42925, 2002.
15. Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., and Van Obberghen, E. Insulin stimulates hypoxia-inducible factor 1 through a phosphotidylinositol 3-kinase/target of rapamycin-dependent signalling pathway. J. Biol. Chem., 277: 27975-27981, 2002.
16. Yaginuma, Y., and Westphal, H. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res., 52: 4196-4199, 1992.
17. Kraus, M. H., Yuasa, Y., and Aaronson, S. A. A position 12-activated H-ras oncogene in all HS578T mammary carcinoma cells but not normal mammary cells of the same patient. Proc. Natl. Acad. Sci. USA. 81: 5384-5388, 1984.
18. Chan, D. A., Sutphin, P. D., Denko, N. C., and Giaccia, A. J. Role of prolyl hydroxylation in oncogenically stabilised hypoxia-inducible factor-1α, J. Biol. Chem., 277: 40112-40117, 2002.
19. Le, N. T. V., and Richardson, D. R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta. 1603: 31-46, 2002.
20. Sotiriou, S., Gispert, S., Cheng, J., Wang, Y., Chen, A., Hoogstraten-Miller, S., Miller, G. F., Kwon. O., Levine, M., Guttentag, S. H., and Nussbaum, R. L. Ascorbic acid transporter S1c23al is essential for vitamin C transport into the brain and for perinatal survival. Nat. Med., 8: 514-517, 2002.
21. Banhegyi, G., Braun, L., Csala, M., Puskas, F., and Mandl. J. Ascorbate metabolism and its regulation in animals. Free Radic. Biol. Med., 23: 793-803, 1997.
22. Head, K. A. Ascorbic acid in the prevention and treatment of cancer. Altern. Med. Rev., 3: 174-186, 1998.